RT @Yuz6Yusof: #EULAR2023 #POS1128 Promising new therapy on the block for #lupus nephritis. A single arm Phase 2a study
Tweet Content
#EULAR2023 #POS1128 Promising new therapy on the block for #lupus nephritis. A single arm Phase 2a study showed Zetomipozomib, selective immunoproteosome-i + MMF showed about 2/3 pts met =>50% reduction in uPCR at WK24. No safety signal including low IgG or infection @RheumNow https://t.co/0A8cCW5GVV
Show on Archive Page
On
Display in Search Results
On
PDQ
Off